BALA CYNWYD, Pa., Aug. 16, 2012 /PRNewswire/ -- Law office of
Brodsky & Smith, LLC announces that it is investigating
potential claims against the Board of Directors of Physicians
Formula Holdings, Inc. ("Physicians Formula" or the "Company")
(Nasdaq: FACE) relating to the proposed acquisition by Swander Pace
Capital, Inc. ("Swander").
Under the terms of the transaction, Physicians Formula
shareholders would receive only $4.25
in cash for each share of Physicians Formula stock they own. The
investigation concerns possible breaches of fiduciary duty and
other violations of state law by the Board of Directors of
Physicians Formula for not acting in the Company's shareholders'
best interests in connection with the sale process to Swander. The
transaction may undervalue Company as Physicians Formula stock
traded at $5.74 on May 12, 2011 and an analyst has set a
$5.00 price target for Physicians
Formula stock.
If you own shares of Physicians Formula stock and wish to
discuss the legal ramifications of the proposed transaction, or
have any questions, you may e-mail or call the law office of
Brodsky & Smith, LLC who will, without obligation or cost to
you, attempt to answer your questions. You may contact
Jason L. Brodsky, Esquire or
Evan J. Smith, Esquire at Brodsky
& Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at
investorrelations@brodsky-smith.com, visiting
http://brodsky-smith.com/468-face-physicians-formula-holdings-inc.html,
or by calling toll free 877-LEGAL-90.
SOURCE Brodsky & Smith, LLC